• 1.

    Almasri J, et al. Outcomes of vascular access for hemodialysis: A systematic review and meta-analysis. J Vasc Surg 2016; 64:236243. doi: 10.1016/j.jvs.2016.01.053

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 2.

    Leermakers JJ, et al. Cost-effectiveness of vascular access for haemodialysis: arteriovenous fistulas versus arteriovenous grafts. Eur J Vasc Endovasc Surg 2013; 45:8492. doi: 10.1016/j.ejvs.2012.10.01

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 3.

    Hicks CW, et al. Mortality benefits of different hemodialysis access types are age dependent. J Vasc Surg 2015; 61:449456. doi: 10.1016/j.jvs.2014.07.091

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 4.

    Al-Jaishi AA, et al. Patency rates of the arteriovenous fistula for hemodialysis: A systematic review and meta-analysis. Am J Kidney Dis 2014; 63:464478. doi: 10.1053/j.ajkd.2013.08.023

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 5.

    Lee T, et al. Long-term outcomes of arteriovenous fistulas with unassisted versus assisted maturation: A retrospective national hemodialysis cohort study. J Am Soc Nephrol 2019; 30:22092218. doi: 10.1681/ASN.2019030318

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 6.

    Hull JE, et al. The pivotal multicenter trial of ultrasound guided percutaneous arteriovenous fistula creation for hemodialysis access. J Vasc Interv Radiol 2018; 29:149158. doi: 10.1016/j.jvir.2017.10.015

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7.

    Beathard GA, Litchfield T, Jennings WC. Two-year cumulative patency of endovascular arteriovenous fistula. J Vasc Access 2020; 21:350356. doi: 10.1177/1129729819877780

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 8.

    Mallios A, et al. Early cannulation of percutaneously created arteriovenous hemodialysis fistulae. J Vasc Access 2019, in press. doi: 10.1177/1129729819892796

    • Search Google Scholar
    • Export Citation

Arteriovenous Access by Nephrologists Percutaneous Creation of Arteriovenous Fistula

  • 1 Umar Waheed, MD, specializes in nephrology and vascular surgery and is affiliated with Banner University Medical Center, Phoenix.
Restricted access

Autologous arteriovenous fistulae (AVF), compared with prosthetic arteriovenous grafts and central vein catheters, are the most effective hemodialysis vascular access option for patients who require renal replacement therapy because of ESKD (1). The effects of autologous AVF include lower thrombosis and infection rates, fewer hospital admissions for access revision, significantly lower mortality rates, increased life expectancy, and lower healthcare-related costs (2, 3).

However, there are many challenges to the successful use of an autologous AVF. One hindrance is the relatively high early thrombosis and failure to mature rate. Surgically created AVF failure rates are

Save